SOBRsafe Announces Exercise of Warrants for $3.1 Million Gross Proceeds

DENVER, COLORADO / ACCESS Newswire / July 15, 2026 / SOBR Safe, Inc. (Nasdaq:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,360,648 shares originally issued in December 2025, having an exercise price of $1.30 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-292709).

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

In consideration for the immediate exercise of the warrants for cash, the Company will issue new unregistered Series E warrants to purchase up to 2,580,648 shares of common stock and new unregistered Series F warrants to purchase up to 2,140,648 shares of common stock. The Series E new warrants will have an exercise price of $1.30 per share, will be exercisable immediately and will expire five years after the effective date of the Resale Registration Statement (as defined below). The Series F new warrants will have an exercise price of $1.30 per share, will be exercisable immediately and will expire twenty-four months after the effective date of the Resale Registration Statement (as defined below).

The aggregate gross proceeds to the Company from the offering are expected to be approximately $3.1 million, before deducting placement agent fees and other offering expenses. The offering is expected to close on or about July 16, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.

The new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the "Act") and, along with the shares of common stock issuable upon their exercise, have not been registered under the Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission ("SEC") or an applicable exemption from such registration requirements. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants (the "Resale Registration Statement").